您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > D8-MMAD
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
D8-MMAD
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
D8-MMAD图片
规格:98%
分子量:779.11
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议
50mg电议
100mg电议

产品介绍
D8-MMAD是MMAD的氘代形式。
货号:ajcx13836
CAS:N/A
分子式:C41H58D8N6O6S
分子量:779.11
溶解度:DMSO: ≥ 100 mg/mL (128.35 mM)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

D8-MMAD is a deuterated form of MMAD, which is a microtubule disrupting agent. IC50 & Target: Tubulin[1]

MMAD (Monomethyl Dolastatin 10) is coupled through a stable oxime-ligation process to yield several near-homogenous antibody-drug conjugates (ADCs) with a drug-to-antibody ratio of ~2.0. The resulting conjugates demonstrate good pharmacokinetic properties, potent in vitro cytotoxic activity against HER2+ cancer cells. When compared with ADCs prepared by cysteine alkylation following native interchain disulfide reduction, site-specific unnatural-amino-acid-based ADCs are shown to have increased in vitro cytotoxicity[1].

The resulting antibody-drug conjugates (ADCs) demonstrate complete tumour regression in rodents. They also have an improved toxicology profile in rats[1].

[1]. Chudasama V, et al. Recent advances in the construction of antibody-drug conjugates. Nat Chem. 2016 Feb;8(2):114-9.